About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Etomidate Versus Propofol in CABG Surgery | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGPhase 4NCT06068764

Etomidate Versus Propofol in CABG Surgery

The objective of this single-blinded randomized controlled interventional clinical trial is to learn about the efficacy and long-term safety of etomidate compared to propofol as an anesthesia inductio...

Lead sponsor: Hartford Hospital•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Aseel Walker, MD

CONTACT

860-972-1778 [email protected]

Sponsors

Lead Sponsor

Hartford Hospital

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Patients scheduled for elective open coronary arteries bypass graft CABG surgery
•2. Patients with American Society of Anesthesiology (ASA) physical status score I- IV
•3. Patients with the ability to speak and read both English and Spanish

Exclusion Criteria

•1. Emergency CABG surgery, STAT cases, and add-on cases.
•2. Refusal or lack of providing the study consent
•3. Patients with a known current adrenocortical insufficiency
•4. A patient who is presenting with any kind of shock, (e.g. septic, hypovolemic, cardiogenic, etc.)
•5. Patients with chronic steroid use (defined as the use of glucocorticoids within 6 months preoperatively)
•6. Patients with a known allergy to etomidate or propofol.
•7. Patients with a known seizure disorder.
•8. Patients who are enrolled in other clinical research studies that can compete with this study.

Related studies

Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque

NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT06779630 · Coronary Artery Disease

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

NCT07565805 · Coronary Artery Disease (CAD)

RECRUITINGPhase 2

Coronary Artery Stents in Heart Failure With Preserved Ejection Fraction

NCT07560436 · Heart Failure With Preserved Ejection Fraction (HFPEF), Coronary Artery Disease

Strategic Comparison Of Ischemia-based Versus Plaque Burden and vulnErability-based Revascularization in High-Risk Coronary Artery Disease Patients

NCT07324720 · Coronary Artery Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: December 28, 2023Terms

Trial snapshot

StatusRECRUITING

PhasePHASE4

Enrollment300

Start dateDec 2023

Last updatedDec 28, 2023

Condition

Coronary Artery Disease

Locations shown

Hartford Hospital

Hartford, Connecticut

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 28, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions